Press Releases

Goldman Sachs (NYSE: GS) Is Under Investigation By The Federal Reserve
Goldman Sachs (NYSE: GS) shares are stuck in neutral as the news cycle is making investors jittery.



Chart Courtesy of StockCharts.com




Sometimes being clever can hurt you. In the case of Goldman Sachs, its Midas touch over the last decade is attracting lots of unwanted attention. Specifically, the company is now in hot water over the credit and currency swaps that it engineered for Greece and that now have threatened the stability of the European Union.

To be sure, this is a very murky situation. At the center of the whole thing is whether Goldman commited any crimes by setting up the swaps, and whether it was just investing smartly when it sold the swaps to a Greek bank several years ago.

Those are questions better left for the legal system and to the Federal Reserve's investigation to answer. What is clear is that Goldman Sachs is in a down cycle, as a company, and that its stock is not what it was even a few months ago, as investors are concerned about what's next for the company.

In our opinion, the real question is whether this is a buying opportunity or whether the shares are better left alone.

And if you look at the chart, it's not clear just yet whether Goldman shares are attractive or otherwise. The company continues to do business, and will likely make money in its upcoming quarters.

Yet, if the Fed's investigation reveals something ultra nasty, there is no telling what could come next, especially with the heavy populism gripping the country and Congress. For now, watching Goldman may be better than owning Goldman.

Make money if any market rises or falls, with a copy of "Market Timing For Dummies."

“Futures And Options For Dummies,” Dr. Duarte’s latest book is now available. The markets are responding to news and geopolitical developments like never before. In this environment, individual investors need to expand their investment horizons. "Futures And Options For Dummies " (John Wiley & Sons) has an excellent section on oil futures as well as the currency markets, while covering and expanding on the successful strategies in Doctor Duarte's other books. Order your copy today.

Doctor Joe Duarte's Market I.Q., offers subscribers a unique blend of intelligence, market commentary and trading strategy. Duarte's daily articles, and news summaries offer recommendations and analysis for ETFs, and individual stocks in the technology, health and biotechnology, and energy sectors. Doctor Duarte is a writer, and an emerging futurist, with a diverse background, and a growing audience. His combined expertise in health care, energy, and the effects of politics and global intelligence on the financial markets offer a unique blend of insight and information to thousands of active investors and political and intelligence aficionados around the world on a daily basis.

He is the author of four books: "Futures And Options For Dummies," "Successful Energy Sector Investing," "Successful Biotech Investing" and co-author of "After-Hours Trading Made Easy."

In early 2001 Dr. Duarte in "Successful Energy Sector Investing," correctly predicted that Venezuela's political problems could lead to an energy crisis in the United States.

In 2003, also Dr. Duarte was among the first to widely publicize the long-term friendship between French President Jacques Chirac and Saddam Hussein.

He has also appeared as a weekly guest on Market Mavens Radio, has logged appearances on KNX radio in Los Angeles, Financial Sense.com radio, and Wall Street Radio.

One of CNBC's original Market Mavens, Dr. Duarte has been writing about the financial markets since 1990.

His articles and commentary have been featured on CBS Marketwatch, Barron's, Smart Money, Medical Economics, and in Technical Analysis of Stocks and Commodities magazines.

In 2003, Doctor Duarte received second place, in the professional section, of the Medical Economics Investment Challenge with a 12-month return of 42%.




Joe-Duarte.com is independently operated and solely funded by subscriber fees. This web site and the content provided is meant for educational purposes only and is not a solicitation to buy or sell any securities or investments. All sources of information are believed to be accurate, or as otherwise stated. Dr. Duarte and the publishers, partners, and staff of Joe-Duarte.com have no financial interest in any of the sources used. For independent investment advice consult your financial advisor. The analysis and conclusions reached on Joe-Duarte.com are the sole property of Dr. Joe Duarte.